What is Global IVD (In Vitro Diagnostics) Products Market?
The Global IVD (In Vitro Diagnostics) Products Market is a vast and dynamic sector that encompasses a wide range of medical devices and technologies used for diagnosing various diseases and medical conditions. These products are designed to be used outside the human body, in a controlled laboratory environment, hence the term 'in vitro', which means 'in glass'. The market includes a variety of products such as reagents, instruments, and systems used for disease diagnosis, monitoring of patient's health status, and prevention of diseases. These products are used in various diagnostic procedures including blood analysis, pathology, immunoassays, molecular diagnostics, and others. The market is driven by the increasing prevalence of chronic and infectious diseases, growing geriatric population, and advancements in diagnostic technologies. However, the market growth is restrained by the high cost of IVD products and stringent regulatory requirements.
Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, Others in the Global IVD (In Vitro Diagnostics) Products Market:
The Global IVD (In Vitro Diagnostics) Products Market is segmented into Immuno Diagnostics, Molecular Diagnostics, Tissue Diagnostics, and Others. Immuno Diagnostics is the largest segment in the market, accounting for over 22% of the total market share. These products are used for detecting and measuring specific proteins or other substances in the body, which are associated with certain diseases or conditions. Molecular Diagnostics involves the analysis of DNA and RNA at the molecular level to detect diseases and monitor patient's health. Tissue Diagnostics involves the examination of tissues to diagnose diseases. The 'Others' segment includes various other types of IVD products such as clinical chemistry, hematology, and microbiology testing products. Each of these segments has its own unique market dynamics, driven by different factors such as technological advancements, changing healthcare practices, and evolving patient needs.
Hospital, Laboratories, Research & Academic, Others in the Global IVD (In Vitro Diagnostics) Products Market:
The Global IVD (In Vitro Diagnostics) Products Market finds its application in various areas such as Hospitals, Laboratories, Research & Academic, and Others. Hospitals are the largest end-users of IVD products, as these products are extensively used for patient diagnosis and treatment monitoring. Laboratories, both clinical and research, also use these products for various diagnostic and research purposes. The Research & Academic segment uses IVD products for research purposes, to study diseases and develop new diagnostic methods. The 'Others' segment includes various other end-users such as home care, point-of-care testing, and others. The usage of IVD products in these areas is driven by factors such as the increasing demand for early and accurate diagnosis, growing healthcare infrastructure, and advancements in IVD technologies.
Global IVD (In Vitro Diagnostics) Products Market Outlook:
The Global IVD (In Vitro Diagnostics) Products Market, which was valued at US$ 84340 million in 2022, is projected to reach a value of US$ 103800 million by 2029. This represents a Compound Annual Growth Rate (CAGR) of 3.5% during the forecast period from 2023 to 2029. The largest segment of the market, in terms of product, is Immuno Diagnostics, which holds a share of over 22%. This data provides a snapshot of the current market scenario, highlighting the market size, growth potential, and the leading market segment. However, it's important to note that the market dynamics are subject to change, influenced by various factors such as technological advancements, changing healthcare practices, regulatory policies, and others.
| Report Metric | Details |
| Report Name | IVD (In Vitro Diagnostics) Products Market |
| Accounted market size in 2023 | US$ 84340 million |
| Forecasted market size in 2029 | US$ 103800 million |
| Base Year | 2023 |
| Forecasted years | 2023 - 2029 |
| Segment by Type |
|
| Segment by Application |
|
| By Region |
|
| By Company | Thermo Fisher Scientific, Roche Diagnostics, Abbott Laboratories, Becton Dickinson, BioMérieuxSA, Immucor, Illumina, Luminex Corporation, CareDx, Hologic, GenDx, Biofortuna, QIAGEN NV, Bio-Rad Laboratories |
| Forecast units | USD million in value |
| Report coverage | Revenue and volume forecast, company share, competitive landscape, growth factors and trends |
